Long‐term secukinumab efficacy and safety in bio‐naïve patients with moderate‐to‐severe cutaneous psoriasis: A real‐world retrospective noninterventional multicentric experience (128 patients)

• Prif Awduron: Francisco Javier Melgosa Ramos (Awdur), Almudena Mateu Puchades (Awdur), Santiago Guillén Climent (Awdur), Marta Galarreta Pascual (Awdur), Marina Saéz Belló (Awdur), María Angels Martínez Ferrer (Awdur), Fernando Toledo Alberola (Awdur), Jorge Magdaleno Tapial (Awdur), Jose Luís Sánchez Carazo (Awdur), Javier Matáix Díaz (Awdur), Luca Schneller‐Pavelescu Apetrei (Awdur), Laura García Fernández (Awdur), Iris González Villanueva (Awdur), Isabel Belinchón Romero (Awdur), Sergio Martín Jiménez (Awdur), Sergio Santos Alarcón (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Wiley, 2023-09-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract Background There is limited evidence over the real‐life secukinumab survival in psoriatic patients, especially in the long‐term bio‐naïve subjects, and to date biological treatments have been assessed in patients with a chronic and recalcitrant psoriasis. It has been hypothesised that early...